Anfarm Hellas S.A. - Main Component
| Active Substance | Strength | Form |
|---|---|---|
| Palonosetron | 250mcg/5ml | Inj.Sol |
| Pantoprazole | 40mg/Vial | Pd.Inj.Sol |
| PosaconazoleUnder Development | 40 mg/mL | Oral Suspension |
| PosaconazoleUnder Development | 100mg/tab | G.R. tabs |
| PosaconazoleUnder Development | 18 mg/mL | C.So.In |
| Active Substance | Strength | Form |
|---|---|---|
| Palonosetron | 250mcg/5ml | Inj.Sol |
| Pantoprazole | 40mg/Vial | Pd.Inj.Sol |
| PosaconazoleUnder Development | 40 mg/mL | Oral Suspension |
| PosaconazoleUnder Development | 100mg/tab | G.R. tabs |
| PosaconazoleUnder Development | 18 mg/mL | C.So.In |
| Active Substance | Strength | Form | Market Availability |
|---|---|---|---|
| Palonosetron | 250mcg/5ml | Inj.Sol | International |
| Pantoprazole | 40mg/Vial | Pd.Inj.Sol | International |
| PosaconazoleUnder Development | 40 mg/mL | Oral Suspension | on going |
| PosaconazoleUnder Development | 100mg/tab | G.R. tabs | on going |
| PosaconazoleUnder Development | 18 mg/mL | C.So.In | on going |
